Related Experiment Video
Updated: Jun 15, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222
Michela Frenquelli1, Marta Muzio, Cristina Scielzo
1Department of Oncology, Unit and Laboratory of Lymphoid Malignancies, San Raffaele Scientific Institute and Universita Vita-Salute San Raffaele, Milan, Italy.
Abstract:
We investigated functional relationships between microRNA 221/222 (miR-221/222) cluster and p27, a key regulator of cell cycle, in chronic lymphocytic leukemia (CLL). The enforced expression of miR-221/222 in the CLL cell line MEC1 induced a significant down-regulation of p27 protein and conferred a proliferative advantage to the transduced cells that exhibited faster progression into the S phase of the cell cycle. Accordingly, expression of miR-221/miR-222 and p27 was found to be inversely related in leukemic cells obtained from peripheral blood (PB) of 38 patients with CLL. Interestingly, when miR-221/222 and p27 protein were evaluated in different anatomic compartments (lymph nodes or bone marrow) of the same patients, increased expression of the 2 miRNAs became apparent compared with PB. This finding was paralleled by a low expression of p27. In addition, when CLL cells were induced in vitro to enter cell cycle (eg, with cytosine phosphate guanine oligodeoxynucleotide), a significant increase of miR-221/222 expression and a marked down-regulation of p27 protein were evident. These data indicate that the miR-221/222 cluster modulates the expression of p27 protein in CLL cells and lead to suggest that miR-221/222 and p27 may represent a regulatory loop that helps maintaining CLL cells in a resting condition.
Insights
MicroRNA 221/222 (miR-221/222) regulates p27 protein levels in chronic lymphocytic leukemia (CLL) cells. This interaction influences cell cycle progression and may maintain CLL cells in a resting state.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Chronic lymphocytic leukemia (CLL) is a B-cell malignancy characterized by the accumulation of leukemic cells.
- The cell cycle regulator p27 plays a crucial role in controlling cell proliferation.
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are implicated in various cancers, including CLL.
Purpose of the Study:
- To investigate the functional relationship between the microRNA 221/222 (miR-221/222) cluster and p27 in chronic lymphocytic leukemia (CLL).
- To determine if miR-221/222 influences p27 expression and cell cycle progression in CLL cells.
Main Methods:
- Enforced expression of miR-221/222 in the MEC1 CLL cell line.
- Analysis of miR-221/222 and p27 protein expression in peripheral blood (PB) and other anatomical compartments (lymph nodes, bone marrow) from CLL patients.
- Induction of cell cycle entry in CLL cells in vitro.
Main Results:
- Enforced miR-221/222 expression in MEC1 cells led to decreased p27 protein levels and enhanced proliferation.
- An inverse correlation between miR-221/222 and p27 expression was observed in leukemic cells from CLL patients.
- Higher miR-221/222 expression and lower p27 levels were found in lymph nodes and bone marrow compared to PB.
- Inducing cell cycle entry in CLL cells increased miR-221/222 expression and decreased p27 protein.
Conclusions:
- The miR-221/222 cluster modulates p27 protein expression in CLL cells.
- miR-221/222 and p27 may form a regulatory loop contributing to the maintenance of CLL cells in a quiescent state.
- These findings highlight a potential therapeutic target for modulating CLL cell proliferation.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules

